| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |